Company Profarm Srl with Fiscal Code 9395060
recorded a turnover of 2024 of
281.619,
with a net profit of
2.188
and having an average number of employees of
2.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Profarm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
137.619
138.881
146.505
143.086
144.745
185.583
205.908
219.414
240.256
281.619
Total Income - EUR
141.235
142.189
152.599
149.581
148.923
193.041
214.932
229.413
252.791
282.137
Total Expenses - EUR
136.840
142.947
150.199
141.242
140.080
184.756
205.607
222.650
250.231
272.577
Gross Profit/Loss - EUR
4.394
-758
2.401
8.340
8.843
8.286
9.325
6.763
2.560
9.560
Net Profit/Loss - EUR
3.691
-759
945
6.964
7.369
6.304
7.176
4.831
272
2.188
Employees
2
2
2
2
2
2
3
3
2
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 17.9%, from 240.256 euro in the year 2023, to 281.619 euro in 2024.
The Net Profit increased by 1.918 euro, from 272 euro in 2023, to 2.188 in the last year.
Check the financial reports for the company - Profarm Srl
Financial Rating - PROFARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Profarm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Profarm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Profarm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
78.634 euro in 2024 which includes Inventories of
58.035 euro, Receivables of
11.721 euro and cash availability of
8.878 euro.
The company's Equity was valued at
12.093 euro, while total Liabilities amounted to
93.677 euro.
Equity increased by 2.188 euro, from 9.961 euro in 2023, to 12.093 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Profarm Srl